| 9:20~9:30 | Opening Remark | 대한뇌졸중학회장 |
| Progress of Acute Stroke Management | 좌장: 김응규 (인제의대) 이덕희 (울산의대) | |
| 9:30~9:55 | Acute thrombolysis | 허지회 (연세의대 신경과) |
| 9:55~10:20 | Neurointerventional thrombolysis | 손철호 (서울의대 영상의학과) |
| 10:20~10:45 | Acute stroke image | 이준 (영남의대 신경과) |
| 10:45~11:00 | Coffee Break | |
| 좌장: 나정호(인하의대) 김의종 (경희의대) | ||
| 11:00~11:25 | Unsettled issues in thrombolysis | 나정호 (인하의대 신경과) |
| 11:25~11:50 | Anti-thrombotics, age issue, minor stroke | 차재관 (동아의대 신경과) |
| 11:50-12:10 | General Assembly | |
| 12:10~12:20 | Intermission | |
| 12:20~13:10 | Luncheon Symposium Ⅰ(Sponsored by Daiichi Sankyo Korea) | 좌장: 정진상 (성균관의대) |
| New option to treat moderate to severe hypertension therapy | Suzanne Oparil(University of Alabama) | |
| Plenary Session | 좌장: 윤병우 (서울의대) | |
| 13:10~14:10 | The Third International Stroke Trial (IST-3): Results, implications and the future of rt-PA |
Richard Lindley (University of Sydney) |
| 14:10~14:40 | Focused update of practice guideline of stroke | 홍근식 (인제의대 신경과) |
| 14:40~15:00 | Coffee Break | |
| Symposium for New Oral Anticoagulants | 좌장: 노재규(서울의대) 이병철(한림의대) | |
| 15:00~15:10 | Introduction for new oral anticoagulants for stroke | 이용석 (서울의대 신경과) |
| 15:10~15:35 | Apixaban for the AF patients with previous stroke or TIA | Michael Hanna(BMS) |
| 15:35~16:00 | Superior efficacy and long-term experience
– how Pradaxa changed the treatment landscape |
Georg Nickenig(University of Bonn) |
| 16:00~16:25 | Rivaroxaban: Secondary prevention of stroke in optimal patient care | Florian Masuhr(German Army Hospital) |
| 16:25~16:40 | Q&A | |
| 16:40~ | Closing | 대한뇌졸중학회장 |
